Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren
Studien
Cft4.0
Caffeine (topical) – Forschung
Überwiegend Mechanismus / Beobachtung
10 begutachtete Studien
Was die Evidenz sagt
Überwiegend Mechanismus / Beobachtung
Die meisten Studien zu Caffeine (topical) sind mechanistisch oder beobachtend statt RCTs, die einen klinischen Effekt messen — betrachte die Ergebnisse als vorläufig.
Die meiste Evidenz stammt aus mittelwertigen randomisierten Studien, veröffentlicht 2007–2026 mit einer typischen Studiengröße von 210 Teilnehmenden.
Basierend auf 10 Studien · 2 RCTs · 253 Teilnehmende insgesamt
Konfidenz
Geringe Konfidenz
Nach Outcome
Hair & nails
Überwiegend Mechanismus / Beobachtung4 Studien
Men's vitality
Zu wenige bewertete Studien2 Studien
Safety profile
Zu wenige bewertete Studien1 Studie
Skin health
Zu wenige bewertete Studien1 Studie
Aktives Forschungsgebiet
5 Studien in den letzten 5 Jahren
200720162026
1Systematische Übersicht2026
We have provided an Oral Dermatoses Map which illustrates key oral conditions and their associated anatomical areas of involvement.
Klein PA, Aristizabal MA, Janovska M, Bruce AJ, Bodiford KJ, Rogers RS. · Journal of the American Academy of Dermatology (2026)
The oral mucosa falls within the purview of dermatology.
It is the responsibility of dermatologists, along with oral medicine specialists, to help bridge this practice gap.
The purpose of this Part II manuscript is to provide differential diagnoses for common oral mucosal conditions based on sites of involvement.
Side effects were mostly limited to localized pain with good outcomes and low recurrence rates.
Anagu O, Salas J, Choe S, Birda A, Sharma A, Baker G, Mesinkovska N. · Italian journal of dermatology and venereology (2025)
In onychomycosis, MAL PDT achieved a 40.9% cure rate and MB PDT showed a 77.8-100% cure rate with no reports of recurrence.
Parasitic infections, such as leishmaniasis have also been successfully treated with both 5-ALA and MAL PDT.
Conclusions PDT is a promising treatment option for cutaneous infections, with growing evidence for its utility in treating cutaneous bacterial, viral, fungal, and parasitic infections, particularly those that fail standard treatments.
Key messages Besides topical tazarotene and vitamin D analogs for nail psoriasis treatment, there is limited evidence for treatment of nail disorders with topical, oral, and intralesional vitamin/vitamin derivatives.
At 6 months, the group of the 5% minoxidil solution showed a mean improvement in anagen ratio of the trichogram of 11.68%, and the group of the 0.2% caffeine solution had an anagen improvement of 10.59%.
Subjects using the phyto-caffeine-containing shampoo had significantly fewer hairs pulled in a hair pull test at 6 months, compared with subjects using the control shampoo (-3.1 vs. -0.5 hairs; P<0.001).
Bussoletti C, Tolaini MV, Celleno L · G Ital Dermatol Venereol (2020)
Single-center, double-blind parallel RCT in women with AGA: a phyto-caffeine shampoo vs control shampoo over 6 months
Caffeine shampoo significantly reduced hairs pulled in the hair-pull test (-3.1 vs -0.5; P<0.001) plus most secondary endpoints; both well tolerated
Caveat: a multi-ingredient 'phyto-caffeine' cosmetic (not caffeine alone), single-center; the abstract reports no numeric sample size (left null, not fabricated)
Significant growth suppression was found in hair follicles treated with 5 microg/ml testosterone. This was counteracted by caffeine in concentrations of 0.001% and 0.005%.
Fischer TW, Hipler UC, Elsner P · Int J Dermatol (2007)
Hair organ-culture model using follicles from biopsies of male AGA patients' vertex scalp
Testosterone suppressed follicle growth; caffeine (0.001-0.005%) counteracted this and caffeine alone significantly stimulated growth (Ki-67 confirmed)
Establishes the androgen-antagonism mechanism for caffeine in AGA — but in-vitro only